Krsnaa Diagnostics Intrinsic Value
Krsnaa Diagnostics intrinsic value. Krsnaa Diagnostics (KRSNAA) median intrinsic value is ₹617.28 from 10 valuation models (range ₹168–₹1119), vs current price ₹559.35 — +10.4% upside (Trading Below Median Value), margin of safety 9.4%. Read Krsnaa Diagnostics dividend payments for the complete payout history and dividend yield track record.
KRSNAA Valuation Methods Summary — DCF, Graham Number & P/E
Krsnaa Diagnostics intrinsic value across 10 models vs current price ₹559.35 — upside/downside and value range per method. For current market price and key ratios, visit KRSNAA stock price BSE.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹617.28 | ₹493.82 - ₹740.74 | +10.4% | EPS: ₹51.44, Sector P/E: 12x |
| Book Value Method | asset | ₹612.50 | ₹551.25 - ₹673.75 | +9.5% | Book Value/Share: ₹612.50, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹448.00 | ₹403.20 - ₹492.80 | -19.9% | Revenue/Share: ₹560.00, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹1118.70 | ₹1006.83 - ₹1230.57 | +100.0% | EBITDA: ₹344.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹761.38 | ₹609.10 - ₹913.66 | +36.1% | CF Growth: 2.8%, Discount: 15% |
| PEG Ratio Method | growth | ₹329.22 | ₹296.30 - ₹362.14 | -41.1% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹423.87 | ₹381.48 - ₹466.26 | -24.2% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹1118.70 | ₹1006.83 - ₹1230.57 | +100.0% | ROE: 17.1%, P/E Multiple: 14x |
| Graham Defensive Method | conservative | ₹841.97 | ₹757.77 - ₹926.17 | +50.5% | EPS: ₹51.44, BVPS: ₹612.50 |
| Dividend Yield Method | dividend | ₹167.81 | ₹151.03 - ₹184.59 | -70.0% | DPS: ₹2.00, Target Yield: 3.5% |
KRSNAA Intrinsic Value vs Market Price — All Valuation Models
Krsnaa Diagnostics fair value range ₹168–₹1119 vs current market price ₹559.35 across 10 valuation models. Compare with KRSNAA DCF valuation to assess whether the stock is under or overvalued.
KRSNAA Intrinsic Value Analysis — Undervalued or Overvalued?
Krsnaa Diagnostics median intrinsic value ₹617.28, current price ₹559.35 — Trading Below Median Value by 10.4%, margin of safety 9.4%.
What is the intrinsic value of KRSNAA?
Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of Krsnaa Diagnostics (KRSNAA) is ₹617.28 (median value). With the current market price of ₹559.35, this represents a +10.4% variance from our estimated fair value.
The valuation range spans from ₹167.81 to ₹1118.70, indicating ₹167.81 - ₹1118.70.
Is KRSNAA undervalued or overvalued?
Based on our multi-method analysis, Krsnaa Diagnostics (KRSNAA) appears to be trading below median value by approximately 10.4%.
KRSNAA Financial Health — Key Ratios vs Industry Benchmarks
Krsnaa Diagnostics financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 1.30 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | 17.1% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 28.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.49x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
KRSNAA Cash Flow Quality — Operating & Free Cash Flow
Krsnaa Diagnostics operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹143 Cr | ₹-55 Cr | Positive Operating Cash Flow | 6/10 |
| March 2025 | ₹87 Cr | ₹37 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹24 Cr | ₹-41 Cr | Positive Operating Cash Flow | 6/10 |
| March 2023 | ₹76 Cr | ₹22 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹128 Cr | ₹8 Cr | Positive Free Cash Flow | 7/10 |